FutureMind Congress: Psychiatry, Psychosomatic Medicine & Mental Health

FutureMind 2026 is a premier global forum where science, clinical care, and innovation converge to reshape mental health. In London over two days, leaders from around the world in psychiatry, psychosomatic research, neuroscience, and digital health will come together to share new knowledge, debate paradigms, and launch scalable solutions.

​This congress is not just about academic exchange — it’s about turning ideas into impact. With keynotes, symposia, workshops, case sessions, and tech showcases, we aim to close the gap between research and real-world use. FutureMind is built to be actionable, inclusive, and future-oriented — a place where attendees don’t just listen but leave ready to transform care delivery.

Attending FutureMind 2026 offers benefits far beyond a typical conference. Here’s what sets it apart:

Hear the latest findings on neuromodulation, psychosomatic pathways, digital diagnostics, and integrated care

• Advance your knowledge: Experience demos of cutting-edge tools — from AI-based decision support to VR therapies and wearables

• See innovation live: Build relationships with global faculty, innovators, policymakers, and collaborators​

• Network with purpose: Present your research or project to international peers and compete for recognition through awards

• Raise your profile: Gain strategies to influence policy, scale care models, and integrate new tools into real systems

• Psychiatrists, psychosomatic medicine specialists, psychologists, neurologists
• Mental health nurses, social workers, and allied care providers
• Health policymakers, system administrators, global health NGOs
• Clinical researchers, neuroscientists, and implementation scientists
• Innovation leaders in pharma, biotech, digital health, and medtech
• Students, trainees, and early-career investigators who wish to grow and connect

FutureMind 2026 is structured into major tracks and sub-tracks, each highlighting a specific dimension of psychiatry, psychosomatic medicine, and mental health innovation. Below are the tracks and their sub-tracks with short descriptions:

Clinical Advances in Psychopharmacology

Long-acting injectables and depot formulations:

Exploring innovations in sustained-release medications that improve adherence and reduce relapse

Adjunctive and augmentation strategies:

Combination approaches to enhance outcomes in treatment-resistant disorders

​

Precision dosing and pharmacogenomics:

How genetic insights and biomarkers personalize treatment and minimize adverse effects

Managing safety, side effects, and metabolic risk:

Best practices in monitoring and mitigating adverse drug effects

​

Novel mechanisms in psychopharmacology:

New targets such as glutamatergic pathways, immune modulators, and neuropeptides in development

Tapering, withdrawal, and long-term maintenance care:

Guidelines for discontinuation and ensuring sustainable recovery​

Neuroscience & Translational Psychiatry

Neuroimaging and functional brain mapping:

Advanced imaging techniques to uncover neural pathways in psychiatric illness.

Circuit-level and connectivity models of illness:

Understanding brain networks and their role in symptoms and treatment response.

​

Immune system and neuroinflammation research:

The role of inflammation and immune responses in mental disorders.

Animal models bridging laboratory to clinical insights:

​Preclinical models that inform human psychiatric research.

​​​

Genetics, epigenetics, and molecular psychiatry:

Latest discoveries linking genetic and epigenetic mechanisms to mental health.

Biomarkers for diagnosis and treatment prediction:

Identifying measurable indicators for early detection and personalized care.

​

Psychosomatic & Brain–Body Integration

Autonomic nervous system and stress regulation:

​

Examining how stress responses influence physical and mental health.

Inflammation and psychiatric comorbidity:

How systemic inflammation contributes to mood and psychosomatic disorders.

Gut–brain axis, microbiome, and psychobiotics:

​

Emerging evidence on microbiota and its role in mood and cognition.

Psychoneuroendocrine mechanisms:

The interplay of hormones, stress, and mental health outcomes.

Functional somatic and medically unexplained syndromes:

Approaches to conditions with overlapping physical and psychiatric features.

Integrative and lifestyle-based interventions:

Holistic strategies including nutrition, exercise, and mind-body practices.

Digital Mental Health & AI Tools

Telepsychiatry and hybrid models of care:

Expanding access through remote consultations and blended approaches.

VR/AR applications in therapy and training:

Immersive technologies for therapy, rehabilitation, and clinician education.

Digital phenotyping and real-time sensing:

Use of smartphones and wearables to track mental health patterns.

Data ethics, privacy, and responsible AI use:

Protecting patient rights while leveraging digital health solutions.

AI-based clinical decision support:

Artificial intelligence tools assisting diagnosis and treatment planning.

Scaling digital therapeutics and mobile interventions:

Strategies for implementing validated digital tools globally.

Event Venue & Nearby Stays

London, United Kingdom

Concerts, fests, parties, meetups - all the happenings, one place.

Get App